OM:EKTA BMedical Equipment
What Elekta (OM:EKTA B)'s FDA Nod for AI CT-Linac and New Vice Chair Means For Shareholders
Elekta recently gained U.S. FDA 510(k) clearance for its Elekta Evo CT-Linac, making the AI‑enhanced radiation therapy system available to American clinics, and the company has also created a new Vice Chair of the Board role, appointing experienced director Tomas Eliasson.
This combination of regulatory progress and governance enhancement highlights Elekta’s focus on expanding its oncology technology footprint while reinforcing board-level support for long-term value creation.
Next, we’ll...